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A B S T R A C T   
Background: Medicine and public health are shifting away from a purely “personal responsibility” model of 
cardiovascular disease (CVD) prevention towards a societal view targeting social and environmental conditions 
and how these result in disease. Given the strong association between social conditions and CVD outcomes, we 
hypothesize that accelerated aging, measuring earlier health decline associated with chronological aging through 
a combination of biomarkers, may be a marker for the association between social conditions and CVD. 
Methods: We used data from the Coronary Artery Risk Development in Young Adults study (CARDIA). Acceler-
ated aging was defined as the difference between biological and chronological age. Biological age was derived as 
a combination of 7 biomarkers (total cholesterol, HDL, glucose, BMI, CRP, FEV1/h2, MAP), representing the 
physiological effect of “wear and tear” usually associated with chronological aging. We studied accelerated aging 
measured in 2005-06 as a mediator of the association between social factors measured in 2000-01 and 1) any 
incident CVD event; 2) stroke; and 3) all-cause mortality occurring from 2007 through 18. 
Results: Among 2978 middle-aged participants, mean (SD) accelerated aging was 3.6 (11.6) years, i.e., the 
CARDIA cohort appeared to be, on average, 3 years older than its chronological age. Accelerated aging partially 
mediated the association between social factors and CVD (N=219), stroke (N=36), and mortality (N=59). 
Accelerated aging mediated 41% of the total effects of racial discrimination on stroke after adjustment for 
covariates. Accelerated aging also mediated other relationships but to lesser degrees. 
Conclusion: We provide new evidence that accelerated aging based on easily measurable biomarkers may be a 
viable marker to partially explain how social factors can lead to cardiovascular outcomes and death.   
1. Introduction 
Cardiovascular disease (CVD), including myocardial infarction, 
stroke, hypertension, and heart failure, is an immense burden on the U.S. 
population. Currently, 35% of Americans over the age of twenty suffer 
from at least one CVD (Benjamin et al., 2019) with higher prevalence of 
46% and 48% among Black men and women, respectively. CVD is also 
the underlying cause for about 31% of all deaths in the U.S. Although a 
declining trend in death from CVD has been observed, due in part to 
advances in prevention and treatment, CVD is still the leading cause of 
death at nearly 50% prevalence in adults over 20 years of age (Benjamin 
et al., 2019). The reasons for this include the increasing age of the 
population and the obesity epidemic and its related morbidities (e.g. 
hypertension, diabetes). Medicine and public health are shifting away 
from a purely “personal responsibility” model of the risk factors for CVD 
towards a more societal view that focuses on the changes in societal and 
environmental conditions, the social determinants of health (SDOH) 
(Das & O’Keefe, 2006; Gebreab et al., 2012; Lagraauw et al., 2015) The 
overwhelming evidence linking SDOH to CVD caused the American 
Heart Association to issue a scientific statement detailing the social 
determinants of risk and outcomes for CVD (Havranek et al., 2015). 
Given the established association between SDOH and CVD outcomes, 
a better understanding of the mechanisms through which SDOH may 
affect cardiovascular health is warranted. Previous research has shown 
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that social stressors such as job strain, marital separation and divorce, 
adverse childhood experiences, and stress associated with medical 
illness are strong predictors of coronary heart disease (CHD) (Ever-
son-Rose & Lewis, 2005). Depression in particular has emerged as a 
potent predictor of cardiovascular diseases (Pedersen et al., 2017). In 
addition to symptoms of depression being a predictor for cardiovascular 
disease, studies have shown that among those with a history of mood 
disorders, racial discrimination is associated with an increased risk of 
cardiovascular disease (David H Chae et al., 2012). The relationship 
between depression and discrimination is found at all socioeconomic 
levels and is actually stronger among African Americans of higher ed-
ucation levels (Hudson et al., 2016) likely because African American 
persons of higher socioeconomic status (SES) occupy more “white 
spaces” increasing the likelihood of discrimination. In order for many 
African Americans to succeed to a place of high education and SES they 
have likely had to find ways to cope with various forms of racial 
discrimination, which can lead to depression (Hudson et al., 2016). 
Various mechanisms through which these factors are associated with 
CVD including activation of the hypothalamic-pituitary-adrenal axis and 
autonomic nervous system, inflammation, blood pressure reactivity, and 
platelet activation have been proposed (Everson-Rose & Lewis, 2005; 
Thomas & Advani, 2006). One possible marker, accelerated aging, has 
emerged from the health disparities literature. The idea of accelerated 
aging leading to poor health outcomes was first presented through 
Geronimus’ weathering hypothesis. Weathering is the phenomenon of 
African Americans showing health declines related to aging earlier than 
Whites due, presumably, to excessive stress (Geronimus, 1992). 
Weathering can be measured indirectly by examining aging and disease 
rates to determine whether disease onset is consistent with the weath-
ering hypothesis (Thorpe et al., 2016) or directly through measures of 
cumulative dysregulation such as allostatic load (Geronimus et al., 
2006), telomere length (Geronimus et al., 2010), and biological age 
(Forrester et al., 2019). Biological age, or the true global aging-related 
state of an organism as it evolves with aging, is intended to quantify 
the aspects of aging that may result from an accelerated chronological 
aging timeline and may be due to stress or other factors. Biological age, 
regardless of the method used, has shown associations with SDOH and 
social factors (Forrester et al., 2019; Geronimus et al., 2010) as well as 
with cardiovascular outcomes and risk factors (Forrester et al., Under 
Revise and Resubmit; Fuster & Andres, 2006; Fyhrquist et al., 2013; 
Haycock et al., 2014; Huzen et al., 2010; Rehkopf et al., 2016). 
1.1. Current study 
Using data from the Coronary Artery Risk Development in Yong 
Adults study (CARDIA), we have previously shown that accelerated 
aging defined as biological age minus chronological age is associated 
with SDOH (socioeconomic status, social participation, depressive 
symptoms) (blinded for review) and that accelerated aging is associated 
with future cardiovascular outcomes (blinded for review). Here, we 
define “social factors” as social determinants of health plus depressive 
symptoms and hypothesize that accelerated aging may capture a com-
bination of explanatory variables that mediate the well-documented 
association of social factors and CVD in the CARDIA cohort. 
2. Methods 
2.1. Cohort description 
CARDIA is a multicenter longitudinal study of 5115 Black or White 
individuals aged 18 to 30 in 1985–86, described in detail elsewhere 
(Friedman et al., 1988). Briefly, following the baseline examination at 
year 0 (Y0) in 1985–86, follow-up examinations were conducted at Y2, 
Y5, Y7, Y10, Y15, Y20, Y25, and Y30 (2015–16). Interim phone or mail 
contacts to ascertain vital status and hospitalizations were conducted 
yearly. At baseline, CARDIA participants had to be free of long-term 
disease and disability and were selected by random sampling after 
stratification so that there would be approximately equal numbers of 
Black and White persons, men and women, ages 18–24 and 25–30 and ≤
12 and >12 years of education at each of the four CARDIA field centers 
in Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA. All 
participants provided informed consent and institutional review board 
approval was obtained at each field center (University of Alabama at 
Birmingham, Northwestern University, University of Minnesota, and 
Kaiser Permanente of Northern California). We excluded 2136 partici-
pants who did not attend the Y20 exam (N=1740, of whom 175 had died) 
or attended but did not have complete biological data at Y20 (N=396) for 
a sample size of 2978. Among Black persons, 38% of those present at 
baseline were not present at Y20 compared to just 23% of Whites. Men 
were more likely to be present at baseline and missing by Y20 compared 
to women and likelihood of presence at baseline and missing at Y20 
decreased as education increased. Among Black men with less than a 
high school education 59% of those present at baseline were missing by 
year 20, the highest of all race/sex/education groups. This pattern of 
missingness is likely to attenuate our results as this group is likely to 
have the most accelerated aging. 
2.2. Measurement 
2.2.1. Biological age/accelerated aging 
Accelerated Aging (AccA) was defined as the difference between 
biological age (BA) and chronological age (CA) (AccA = BA – CA) so that 
a positive value indicates that a person is biologically older than their 
chronological age and conversely a negative value indicates that a 
person is biologically younger than their CA. BA was calculated with the 
Klemera & Doubal Method (KDM)(Klemera & Doubal, 2006), as a linear 
combination of selected biomarkers associated with age and derived 
from regressions of chronological age on each biomarker. The KDM 
method uses the intercept, slope, and root mean squared error to solve 
the regression equation biomarker ~ chronological age in standardized 
units of the biomarker, and combines these estimated biological ages 
into BA, using CA, which shrinks BA toward CA. This results in BA being 
a linear combination of the biomarkers included in the calculation. In 
order to calculate biological age so that it represents the approximate 
chronological age at which a person in the general population would 
have the combination of biomarkers corresponding to the biological age, 
we used a reference dataset from NHANES to calculate the biological age 
parameters and applied the parameters to the CARDIA dataset (Levine, 
2013). We used NHANES participants from 2007 through 2010 (the only 
consecutive years in which both c-reactive protein and lung function 
measures were available) that were non-pregnant and aged between 30 
and 75 years. We ran the series of regressions required by KDM and 
calculated the parameters and then used the parameters along with the 
CARDIA participant’s chronological ages to create the final BA. We used 
4-year weights provided by NHANES to ensure that our results are 
representative of the general population. 
We selected 7 biomarkers based on general knowledge of their as-
sociation with aging, availability in CARDIA, and significant association 
with CA in CARDIA: total and HDL cholesterol (mg/dL), glucose (mg/ 
dL), body mass index (BMI), c-reactive protein (CRP) (mg/L), forced 
expiratory volume in 1 s (FEV1/h2) (liters), and mean arterial pressure 
(MAP; MAP = diastolic bp2 + systolic bp/3) (mmHg) see (Friedman 
et al., 1988) and (Lakoski et al., 2006) for more detail on biomarker 
measurement). We used biomarkers from the Y20 exam in 2005–2006. 
2.2.2. Morbidity and mortality 
Morbidity and mortality endpoints are determined through annual 
participant contacts, death certificates, and relevant medical and hos-
pital records. Events are adjudicated by the CARDIA Endpoints Sur-
veillance and Adjudication Committee (ESAS) according to established 
protocol (Bibbins-Domingo et al., 2009). In examining the temporal 
relationship between accelerated aging and morbidity and mortality, we 
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used endpoints beginning in 2007 and ending in 2016 for morbidity and 
2018 for mortality. Events before 2007 were not included in the analysis 
but the participants were not excluded. Thus, our endpoints are incident 
events, but do not necessarily represent incident CVD (although in 99% 
of cases they do). As an individual with CVD before 2007 might still have 
an incident event between 2007 and 2018, we performed a sensitivity 
analysis excluding participants who had undergone an event before 
2007. Our CVD endpoint was defined as having at least one of the 
following endpoints between 2007 and 2018: myocardial infarction 
(MI), non-MI acute coronary syndrome (non-MI ACS), coronary revas-
cularization, congestive heart failure (CHF), stroke, transient ischemic 
attack (TIA), coronary artery disease (CAD), peripheral artery disease 
(PAD), deep vein thrombosis (DVT), pulmonary embolism (PE), atrial 
fibrillation (AF), or death attributable to CVD. 
2.2.3. Race 
Race was self-reported at baseline (1985–1986) as Black/African 
American or White/Caucasian; ethnicity was not ascertained. 
2.2.4. Depression symptoms (measured at Y15.) 
The Center for Epidemiological Studies – Depression Scale (CES-D) 
(Radloff, 1977), a 20-question scale that asks about frequency of expe-
riencing symptoms of depression (e.g. sleep changes, weight changes, 
“feeling blue”) measured depression symptoms. Responses range from 
0 (none of the time) to 3 (most or all of the time) for a total score range of 
0-60. 
2.2.5. Socioeconomic status (measured at Y15) 
Socioeconomic status (SES) included 7 categorical variables: edu-
cation level (less than high school [<12 years], high school [9-12 years], 
undergraduate [13-16 years], graduate school [17-20 years]), difficulty 
paying for medical expenses (very hard to not very hard), difficulty 
paying for basics, income (<$5000 to >= $100,000 in $10,000 in-
crements), assets (<=$500 to >=$500,000 in $10,000 increments), 
home status (owned or being bought to occupied without payment of 
money), and food insecurity (often don’t have enough food to have 
enough food and kinds of food). We conducted a factor analysis and used 
a factor score where a higher score indicated higher socioeconomic 
status. The score derived from the factor analysis is hereafter referred to 
as “SES score.” 
2.2.6. Discrimination (measured at Y15.) 
Racial and socioeconomic discrimination were measured via the 
Experiences of Discrimination Scale (Williams et al., 1997). The scale 
asks about discrimination in seven domains–at school, finding a job, 
work, housing, medical care, home, and in public. The Experiences of 
Discrimination Scale has a score range of 0 to 7 for each subscale. Each 
subscale asks if the respondent has been discriminated against or made 
to feel inferior due to a given factor (e.g., race, SES, gender, age). Racial 
discrimination and SES discrimination were separate subscales and 
therefore there was no overlap in attribution of discrimination. In 
keeping with previous CARDIA analyses (Borrell et al., 2013) we 
modeled discrimination categorically. Each discrimination variable 
(racial and SES) was defined as endorsing 3 or more domains of 
discrimination within the respective subscale, less than 3 domains, or 
none. 
2.2.7. Social participation 
(measured at Y15.) was ascertained from a questionnaire querying 
the types of groups that a participant may belong to (e.g. church groups, 
unions, community groups, etc.). Social participation was defined as a 
continuous score that represented the number of groups reported (0–6). 
Social participation score was used from the exam. 
2.2.8. Covariates 
Sex, study site, chronological age, smoking, and alcohol use were 
used as adjustment variables in analysis. Sex is well known to be asso-
ciated with CVD outcomes while chronological age is associated with 
both AccA and CVD outcomes. There is known variation in health status 
by site in the CARDIA dataset. In this study CVD and mortality differed 
by site as did AccA. Sex was self-reported as male or female. Site indi-
cated at which center the participant had their baseline interviews 
conducted. Smoking was defined as never/former smokers vs. current 
smokers at Y20. Alcohol use was defined as mL alcohol per day at Y20. 
Chronological age was defined as age at Y20. 
2.3. Statistical analysis 
All analyses used morbidity or mortality endpoints as outcomes. 
Most morbidity endpoints (above) had prevalence <1% between 2007 
and 2018 so we created a composite CVD endpoint (above). CVD was 
modeled as absent or present where present indicated that at least one 
cardiovascular endpoint was adjudicated between 2007 and 2018. The 
cardiovascular endpoints included in the CVD variable are based on the 
American Heart Association’s definition of CVD (American Heart Asso-
ciation, 2017). Although hypertension and diabetes were more preva-
lent than CVD in the sample, we omitted them as individual outcomes 
because serum glucose and mean arterial pressure are included in the 
biological age equation. The analysis was completed with the following 
endpoints – CVD, stroke, and all-cause mortality. Although stroke is 
included in the CVD definition, we chose to analyze stroke as a separate 
endpoint because it is historically racially disparate and significantly 
different by race in this sample. Social factors were measured in 
2000–2001 (Y15), accelerated aging was measured in 2005–2006 (Y20) 
and morbidity and mortality endpoints were measured between 2007 
and 2018. 
We measured the unadjusted relationship between each social 
determinant variable and each endpoint separately using logistic 
regression. Those social variables that were significantly associated with 
any of the endpoints were retained for mediation analyses. We tested for 
mediation using the Binary Mediation program in Stata 15, which 
standardizes the coefficients and then uses the product of coefficients 
approach to measure indirect effects, both with and without adjustment 
for covariates. Binary Mediation uses the Baron and Kenny (Baron & 
Kenny, 1986) approach to measuring mediation but can also handle 
both dichotomous and continuous variables. We used bootstrapping to 
obtain standard errors and 95% confidence intervals for the direct and 
indirect effects. Analyses were done with Stata 15 (StataCorp, 2017) and 
R 4.0 (R Core Team, 2017). 
2.3.1. Mediation analysis 
See Fig. 1 for a conceptual model and a visual representation of the 
following explanation of the binary meditation analysis. The binary 
mediation program runs a series of regression analyses: (1) the regres-
sion of the mediator (accelerated aging) on the predictor (social deter-
minant variable) results in the “path a” coefficient; (2) the regression of 
the outcome (morbidity/mortality) on the predictor (social determinant 
variable) results in the “path c” coefficient”; and (3) the regression of the 
outcome (morbidity/mortality) on the mediator (accelerated aging and 
the predictor (social determinant variable) results in the “path b” coef-
ficient (accelerated aging) and the “path c’ (c-prime)” coefficient (social 
determinant variable). For each regression that includes the dichoto-
mous morbidity/mortality outcomes, the binary mediation program 
standardizes each estimate by the standard deviation of the predictor 
and the outcome and uses the product of the coefficients approach to 
calculate the indirect effect. See MacKinnon & Dwyer (Mackinnon & 
Dwyer, 1993) for the equations used in binary mediation to compute 
direct, indirect, and total effects. Briefly, the indirect effect is the result 
of multiplication of the path a and standardized path b coefficients. The 
direct effect is the standardized path c’ coefficient (the association be-
tween the predictor and outcome adjusted for the mediator). The total 
effect is calculated as path a*path b + path c’. Finally, the percentage of 
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total effect mediated is the percentage of the total effect that is indirect 
and is calculated as indirect effect/total effect * 100. 
We first ran unadjusted binary mediation models for each outcome 
and the social determinant variables that were significantly associated 
with each outcome and used the bootstrap estimation approach with 
500 samples to test the significance of the direct, indirect, and total ef-
fects. We next repeated each of the models in binary mediation adjusting 
for sex, chronological age, race, site, smoking status, and mL alcohol per 
week. 
2.3.2. Sensitivity analyses 
Our main analysis was a complete case analysis that included only 
those who had complete biological data at Y20. Among participants with 
a CVD outcome, 34% were missing biological data at Y20, and among the 
234 participants who died between 2007 and 2018, 75% were missing 
biological data at Y20. To see whether these exclusions influenced our 
results, we completed a sensitivity analysis using multiple imputation, 
based on exams prior and subsequent to Y20 to include those who were 
not available at Y20. We used multiple imputation, using the multivar-
iate normal distribution, to impute missing biological data for those who 
were lost by attrition. We created 10 sets of imputed data and pooled the 
results across them. We then used the imputed datasets in the KDM 
calculations and conducted the same analyses (unadjusted logistic 
regression, unadjusted binary mediation, adjusted binary mediation) as 
previously using the imputed dataset. We completed a second sensitivity 
analysis where excluding participants who had a cardiovascular outcome 
before 2007 (n = 25). 
3. Results 
3.1. Cohort description 
Our sample consisted of 2978 Black or White participants with a 
mean chronological age of 45 years in 2005–2006 (Y20 -Table 1). In the 
overall sample, accelerated aging (AccA) was 3.62 (SD = 11.7). Black 
persons had higher average accelerated aging than Whites (9.93 years 
versus minus 1.43 years) and women had lower average accelerated 
aging than men (3.34 years versus 3.99). The parameters used to 
calculate biological age-BA (intercept, slope, root mean squared error 
and r2 taken from regressions of age on biomarkers) were calculated in 
the NHANES reference sample and applied to the CARDIA sample (see 
Supplemental Table 1 for parameters used to calculate BA). When BA 
parameters weren’t independent of the CARDIA sample (e.g. BA pa-
rameters calculated in the CARDIA sample and then applied to the 
CARDIA sample) they were less precise (higher SDs). There were 219 
participants (7%) with CVD events after Y20 in the final sample and 59 
all-cause deaths after Y20 (2%). The mean CES-D score at Y15 in the 
sample was about 8.7 (SD = 7.7) and about 21% reported racial 
discrimination in more than 3 domains with 19% of the total percentage 
reported among Black persons. 
3.2. Mediation analysis 
In our initial, unadjusted analysis we tested depression symptoms, 
SES score, racial discrimination, SES discrimination, and social 
Fig. 1. Conceptual model of the hypothesized relationships between social determinants, accelerated aging, and cardiovascular outcomes. Where “c” is the rela-
tionship between stressors and the outcome not adjusted for accelerated aging; “a” is the relationship between stressors and accelerated aging; “b” is the relationship 
between accelerated aging and the outcome; and “c’ ” (c-prime) is the relationship between stressors and the outcome adjusted for the mediator, accelerated aging. 
Table 1 
Summary Statistics for Accelerated aging, Demographics, and Biomarkers: 
CARDIA, 2000–2018.   
Total (n =
2978) m (sd) or 
n (%) 
Black (n =
1324) m (sd) or 
n (%) 
White (n =




45.3 (3.6) 44.6 (3.8) 45.8 (3.4) 
Biological Age (Y20) 48.9 (11.9) 54.5 (10.0) 44.4 (11.3) 
Accelerated aging 
(Y20) 
3.62 (11.7) 9.9 (9.3) -1.4 (10.8) 
Female (Y20) 1706 (57%) 821 (62%) 885 (53%) 
Current smoker(Y20) 532 (18.0) 313 (23.8) 219 (13.4) 
mL Alcohol/week (Y20) 10.9 (21.8) 8.6 (22.5) 12.7 (21.2) 
Exercise score (EU) 
(Y20) 
342.5 (275.0) 297.5 (282.7) 378.9 (263.0) 
CES-D (Y15) 8.7 (7.7) 10.2 (8.3) 7.6 (7.0) 
SES Factor Score (Y15) 4.6 (1.2) 4.0 (1.2) 5.0 (1.0) 
Racial Discrimination 
(Y15) 
0.67 (0.8) 1.2 (0.8) 0.3 (0.5) 
Social Participation 
(Y15) 
7.7 (1.4) 7.7 (1.5) 7.7 (1.4) 
Total Cholesterol (mg/ 
dL) (Y20) 
186.2 (34.8) 184.2 (35.6) 187.7 (34.1) 
HDL Cholesterol (mg/ 
dL) (Y20) 
54.3 (16.6) 54.4 (16.2) 54.2 (17.0) 
Glucose (mg/dL) (Y20) 97.5 (25.0) 99.6 (30.0) 95.8 (19.9) 
Body Mass Index (Y20) 29.4 (7.1) 31.4 (7.4) 27.8 (6.5) 
C-reactive protein 
(mg/L) (Y20) 
2.7 (4.5) 3.6 (5.3) 2.0 (3.5) 
FEV1/h2 (liters) (Y20) 3.1 (0.8) 2.7(0.7) 3.3 (0.8) 
Mean arterial pressure 
(mmHg) (Y20) 
87.3 (12.0) 91.1 (12.4) 84.3 (10.8) 
Cardiovascular Disease 
(2007–2018) 
219 (7%) 125 (9%) 94 (6%) 
Stroke (2007–2018) 36 (1%) 29 (2%) 7 (0.42%) 
Mortality (2007–2018) 59 (2%) 29 (2%) 30 (2%) 
FEV1/h2 = Forced expiratory volume in 1 s/height2; EU = Exercise Units; CES-D 
= Center for Epidemiologic Studies Depression Scale. 
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participation as predictors of each outcome based on a previous finding 
showing that these variables are associated with AccA in CARDIA 
(blinded for review) and we found significant relationships between 
depression symptoms and CVD, socioeconomic status and CVD, 
depression symptoms and stroke, racial discrimination and stroke, SES 
and stroke, depression symptoms and death, social participation and 
death, and SES and death. All social determinant variables were signif-
icantly associated with accelerated aging. We therefore proceeded to 
study the mediating effect of accelerated aging for eight of the statisti-
cally significant associations noted in Table 2. 
3.2.1. Cardiovascular disease 
Our initial analysis of social factors and morbidity and mortality 
outcomes showed that depression symptoms and socioeconomic status 
score were significant predictors of cardiovascular disease (Table 2). 
Table 3 shows the results of the unadjusted and adjusted binary medi-
ation analyses for depression and socioeconomic status. Both adjusted 
and unadjusted analyses of the relationship between depression and 
cardiovascular disease are consistent with accelerated aging as a partial 
mediator of this relationship. The results are consistent with partial 
mediation because when the mediator is included in the model the co-
efficient for the relationship between CVD and depression is attenuated 
but remains statistically significant (0.10, 95% CI: 0.03, 0.17). 
Approximately 8% of the association between depression and CVD is 
accounted for by accelerated aging and covariates. Similarly, the un-
adjusted relationship between socioeconomic status and CVD is consis-
tent with partial mediation by accelerated aging (-0.09, 95% CI: -0.17, 
-0.02) (Fig. 2). After adjustment the model was consistent with AccA 
fully mediating the relationship between SES and CVD as the addition of 
AccA to the model rendered path between SES and CVD no longer sta-
tistically significant (-0.08, 95% CI: -0.16, 0.01). 
3.2.2. Stroke 
Table 4 shows the unadjusted and adjusted binary mediation results 
for the models with stroke as the outcome. 
Fig. 3 illustrates the mediation analysis findings for accelerated aging 
as a mediator of the effect of depression symptoms on stroke. In unad-
justed analyses the relationship between depression and stroke was 
significant as was the relationship between depression and accelerated 
aging. The direct effect remained significant in the presence of the 
mediator indicating partial mediation with 22% of the association be-
tween depression and stroke mediated by AccA. Adjusted analyses 
showed an attenuated association that rendered the direct effect not 
statistically significant consistent with full mediation (0.14, 95% CI: 
-0.01, 0.29). 
Unadjusted analyses with racial discrimination as the predictor 
showed a significant association between discrimination and stroke and 
discrimination and accelerated aging but a non-significant direct effect 
(0.13, 95% CI: -0.07, 0.31) indicating full mediation (Fig. 4). Adjusted 
analysis showed similar results (direct effect = 0.15, 95% CI: -0.06, 
0.33). Consistent with the previous predictors, unadjusted analysis of 
SES and stroke indicated full mediation with insignificant direct effects 
(-0.06, 95% CI: -0.21, 0.16). In adjusted analysis, only the indirect ef-
fects remained significant (-0.04, 95% CI: -0.02, -0.06) while the direct 
effect was not significant and it flipped from a negative association to a 
positive association (0.04, 95% CI: -0.16, 0.24). The proportion medi-
ated was -4.86 (486%) because in the presence of the mediator and the 
covariates, higher socioeconomic status was associated with increased 
likelihood of a stroke outcome (as opposed to decreased likelihood in the 
unadjusted model), though not significantly. This indicates inconsistent 
mediation and possible suppressor effects. 
3.2.3. Mortality 
Table 5 shows the results of the unadjusted and adjusted binary 
mediation analysis with all-cause mortality. Unadjusted relationships 
between depression, accelerated aging, and mortality were consistent 
with partial mediation as the direct effect remained significant (0.21, 
95% CI: 0.09, 0.30) in the presence of the mediator. Adjustment for 
covariates resulted in slight attenuation of the effects but the association 
remained partially mediated. 
The association between SES and mortality showed partial mediation 
by accelerated aging similar to mortality and depression. The associa-
tion between SES and mortality was significant as was the relationship 
between SES and accelerated aging. The direct effect between SES and 
mortality remained significant when accelerated aging was included in 
the model (-0.24, 95% CI: -0.35, -0.11). Addition of covariates attenu-
ated the relationship between SES and mortality thus reducing the in-
direct effect, but the direct effect remained similar (-0.26, 95% CI: -0.40, 
-0.11) and the effect remained consistent with partial mediation. Social 
participation showed a similar association consistent with partial 
Table 2 
Unadjusted odds ratios (95% confidence intervals) for morbidity/mortality 
endpoints in 2007–2018 on social factors in 2000–2001: CARDIA, 2000–2018a.   
CVD OR (95% 
CI) 
Stroke OR (95% 
CI) 






1.05 (1.02, 1.09) 1.06 (1.03, 1.08) 
SES Score 0.79 (0.71, 
0.89) 





1.75 (1.17, 2.60) 0.98 (0.70, 1.37) 
SES Discrimination 1.10 (0.90, 
1.34) 
1.07 (0.68, 1.70) 1.18 (0.84, 1.68) 
Social Participation 0.98 (0.88, 
1.08) 
0.93 (0.73, 1.19) 0.74 (0.60, 0.92) 
Units: 1-point increment in each social factor. 
a Bold type denotes significant association. 
Table 3 
Binary Mediation Coefficients for Accelerated aging at Y20 (2005–2006) Medi-
ating the Relationship between Social Factors at Y15 (2000–2001) and Cardio-
vascular Disease after at Y20 (2007–2016): CARDIA, 2000–2016*.   
Depression Score (Points, 
Continuous) 

























































24.35% 7.82% 39.78% 22.52% 
Note. 
a Path a = pathway from independent variable (depression score or SES score) 
to mediator (accelerated aging); Path b = pathway from mediator (accelerated 
aging) to outcome (cardiovascular disease). The coefficient for Path a corre-
sponds to the association between the independent variable and the mediator; 
the coefficient for path b corresponds to the association between the mediator 
and the outcome; a*b corresponds to the effect of the mediation. 95% CI of a*b is 
bias-corrected and tests whether different than zero; The total effect of X on Y 
reports the indirect and direct effect of the independent variable on the outcome; 
percent total effect mediated is the percentage of the outcome that can be 
attributed to the mediator. 
b Adjusted for sex, chronological age, race, site, smoking status, and mL 
alcohol per week. 
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mediation where the direct effect remained significant when the medi-
ator was added to the model (-0.21, 95% CI: -0.37, -0.06). Adjustment 
for covariates attenuated the association but the direct effect (-0.19, 
95% CI: -0.34, -0.03) and overall partial mediation remained the same. 
3.3. Sensitivity analysis 
For the first sensitivity analysis, imputing values not available at Y20, 
the main difference from the primary results was in the association be-
tween socioeconomic status and outcomes in the unadjusted logistic 
regression analysis. The primary analysis only showed a significant as-
sociation between socioeconomic status and CVD whereas the analysis 
on the full imputed sample showed a significant association with all 
three primary outcomes. The binary mediation analyses were similar, 
though slightly attenuated, in the imputed sample versus the primary 
analysis (results not shown). The second sensitivity analyses excluding 
participants without cardiovascular outcomes before 2007 showed 
similar results as the primary analysis (results not shown). 
4. Discussion 
We found that accelerated aging, based on a linear combination of 
clinical biomarkers, could partially explain the association between 
social factors and CVD morbidity and mortality. Although previous 
studies have explored the association between other measures of 
accelerated aging (e.g. telomere length) and cardiovascular outcomes 
and mortality, we know of no studies examining accelerated aging as a 
function of biological and chronological age in this manner. Our findings 
are consistent with the hypothesis that accelerated aging may represent 
the mechanism relating social factors to cardiovascular outcomes. 
4.1. Social factors and morbidity/mortality 
An abundance of literature has confirmed the association of social 
factors and cardiovascular outcomes and death. The importance of this 
field of research is illustrated by the term “behavioral cardiology” 
(Rozanski, 2014). A common theme in this literature is the robust 
Fig. 2. Unadjusted Mediation Model of SES, Accelerated aging, and CVD. a = pathway from SES to accelerated aging; b = pathway from accelerated aging to CVD; c 
= unadjusted pathway from SES to CVD; c’= pathway from SES to CVD adjusted for accelerated aging. Indirect effects = a*b; Direct effect = effects of SES on CVD in 
the presence of accelerated aging (c’); Total effects = indirect effect + direct effect. Numbers refer to standardized coefficient (bias-corrected 95% confidence in-
terval) for each path. 
Table 4 
Binary Mediation Coefficients for Accelerated aging at Y20 (2005–2006) Mediating the Relationship between Social Factors at Y15 (2000–2001) and Stroke after at Y20 
(2007–2016): CARDIA, 2000–2016.   
Depression Score (Points, Continuous) Racial Discrimination Score (Points, 
Continuous) 
Socioeconomic Status Score (Points, 
Continuous) 












Path a 0.12 (0.09, 0.16) 0.03 (-0.001, 
0.07) 
0.30 (0.26, 0.34) 0.28 (0.24, 0.31) -0.26 (-0.30, 0.22) -0.09 (-0.13, 
-0.06) 
Path b 0.38 (0.23, 0.53) 0.33 (0.12, 0.54) 0.37 (0.22, 0.52) 0.37 (0.19, 0.56) 0.40 (0.23, 0.56) 0.37 (0.15, 0.60) 
a*b (indirect effect of X on Y) 0.05 (0.03, 0.07) 0.01 (0.003, 
0.02) 
0.11 (0.07, 0.15) 0.10 (0.06, 0.15) -0.10 (-0.14, -0.07) -0.04 (-0.06, 
-0.02) 
Total Effect of X on Y 0.21 (0.10, 0.31) 0.15 (-0.01, 0.27) 0.25 (0.07, 0.41) 0.25 (0.06, 0.42) -0.16 (0.02, -0.31) 0.01 (-0.21, 0.26) 
Percent total effect mediated (% indirect of 
total effect) 
22.49% 7.33% 46.22% 40.84% 68.45% -485.89%d 
The coefficient for Path a corresponds to the association between the independent variable and the mediator; the coefficient for path b corresponds to the association 
between the mediator and the outcome; a*b corresponds to the effect of the mediation. 95% CI of a*b is bias-corrected and tests whether different than zero; The total 
effect of X on Y reports the indirect and direct effect of the independent variable on the outcome; percent total effect mediated is the percentage of the outcome that can 
be attributed to the mediator. 
a Path a = pathway from independent variable (depression score, racial discrimination, or SES score) to mediator (accelerated aging); Path b = pathway from 
mediator (accelerated aging) to outcome (stroke). 
b Adjusted for sex, chronological age, race, site, smoking status, and mL alcohol per week. 
c Model with racial discrimination as independent variable not adjusted for race. 
d Addition of covariates suppressed direct effect resulting in inconsistent mediation. 
S.N. Forrester et al.                                                                                                                                                                                                                             
SSM - Population Health 13 (2021) 100733
7
association of depression and cardiovascular outcomes. both predicts 
incident CVD and worse outcomes in those with CVD (Pedersen et al., 
2017). In our fully adjusted models, we found that each one-point in-
crease in CES-D score was associated with an increase in the odds of any 
CVD, stroke, and death, confirming the association. We also found that 
higher socioeconomic status was associated with a decreased risk of 
cardiovascular disease, stroke, and mortality. 
4.2. Accelerated aging mediates the relationship between social factors 
and health outcomes 
This hypothesis was designed to expand our finding from a previous 
report where we demonstrated that social factors could predict later 
accelerated aging (blinded for review). Our mediation analyses revealed 
that accelerated aging is a possible pathway for the associations between 
certain social factors (depression, racial discrimination, socioeconomic 
status, social participation) and cardiovascular outcomes. The strongest 
relationships that we found (based on proportion of effect mediated after 
adjustment) were between SES and CVD, and racial discrimination and 
stroke. This is particularly interesting in light of other research showing 
that higher SES tends to be better for mental and physical health but that 
among Black persons in particular, racial discrimination may cancel out 
the positive effects of higher SES (Hudson et al., 2012). This phenome-
non could be due to the high effortful coping or “John Henryism” that is 
often required of Black persons who achieve high socioeconomic status 
(Hudson et al., 2016; McKetney & Ragland, 1996). Black persons are far 
less likely than White persons to be upwardly mobile (being born into a 
low SES and move up to a higher SES in adulthood) and when they do, 
they face many more obstacles including racial discrimination, the toll 
of which can lead to depression (Hertz, 2009, p. 165) and ultimately 
affect cardiovascular health. This research would benefit from a future 
analysis with greater power to test interactions between racial 
discrimination and depression among Black persons. 
As previously discussed, depression has been linked to cardiovas-
cular outcomes. Wolkowitz et al. have proposed a model in which major 
depressive disorder (MDD) causes accelerated aging through biochem-
ical mediators associated with the HPA axis, oxidative stress, inflam-
mation, and others, and accelerated aging results in disease (Wolkowitz 
Fig. 3. Unadjusted Mediation Model of Depression, Accelerated aging, and Stroke. a = pathway from depression to accelerated aging; b = pathway from accelerated 
aging to stroke; c = unadjusted pathway from depression to stroke; c’= pathway from depression to stroke adjusted for accelerated aging. Indirect effects = a*b; 
Direct effect = effects of depression on stroke in the presence of accelerated aging (c’); Total effects = indirect effect + direct effect. Numbers refer to standardized 
coefficient (bias-corrected 95% confidence interval) for each path. 
Fig. 4. Unadjusted Mediation Model of Racial Discrimination, Accelerated aging, and Stroke. a = pathway from racial discrimination to accelerated aging; b =
pathway from accelerated aging to stroke; c = unadjusted pathway from racial discrimination to stroke; c’= pathway from racial discrimination to stroke adjusted for 
accelerated aging. Indirect effects = a*b; Direct effect = effects of racial discrimination on stroke in the presence of accelerated aging (c’); Total effects = indirect 
effect + direct effect. Numbers refer to standardized coefficient (bias-corrected 95% confidence interval) for each path. 
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et al., 2010, 2011). Although we didn’t measure diagnosed MDD, our 
findings support this model as our results were consistent with accel-
erated aging mediating the relationship between depression symptoms 
and stroke and depression symptoms and CVD overall. Others have also 
shown that MDD was associated with another measure of accelerated 
aging, shortened telomeres (Verhoeven et al., 2014). Our other major 
finding, that accelerated aging fully mediates the relationship between 
racial discrimination and stroke is less clear cut. 
Although discrimination has been repeatedly linked to mental health 
outcomes, perceived discrimination as a risk factor for disease and poor 
health, has produced inconsistent results. Perceived discrimination 
(both overall and race-specific) has been associated with blood pressure 
(Krieger & Sidney, 1996), self-rated health (Colen et al., 2018), hyper-
tensive status (Cozier et al., 2006; Dolezsar et al., 2014), risk of CVD (D. 
H. Chae et al., 2010), elevated diastolic blood pressure (Lewis et al., 
2009), coronary artery calcification (Everage et al., 2012; Lewis et al., 
2006), and poor physical and mental health (Borrell et al., 2006). The 
findings are mixed, however, because most of the relationships have 
qualifiers such as beliefs about Black people, chronological age, type of 
discrimination (lifetime versus chronic), nativity and childhood resi-
dence, and coping. Clark et al. propose a biopsychosocial model of 
racism as a stressor for African Americans (Clark et al., 1999). Our re-
sults seem to partially confirm this model; however, we were unable to 
stratify by race and hence cannot confirm that the model is specific to 
African Americans. Although African Americans by far reported the 
most racial discrimination (75% reported any racial discrimination, and 
45% reported racial discrimination in three or more domains), 23% of 
Whites also reported some racial discrimination and a small proportion 
reported racial discrimination in three or more domains (3%). It is likely 
that the perception of racial discrimination is different by race and 
adjusting for race did significantly attenuate the relationship between 
racial discrimination and stroke (results not shown), indicating that 
racial discrimination experienced by Black persons likely drives the 
significant relationship. 
Various biological mechanisms have been proposed for these asso-
ciations including autonomic nervous system dysfunction, endothelial 
dysfunction, inflammation, prothrombotic state, and increased stress 
reactivity (Pedersen et al., 2017). Our findings may also encompass 
multiple previously delineated mechanisms. Inflammation for instance 
was part of our biological age measure so it is included in the definition 
of accelerated aging. The weathering hypothesis as originally stated was 
intended to show how chronic stress affected physical health so 
increased stress reactivity should, in theory, be captured by any measure 
of weathering. Presumably, our measure of accelerated aging is more 
comprehensive than inflammation or HPA axis dysfunction alone, and it 
is also easier to measure. The stark racial differences in accelerated 
aging also make it a candidate for a marker of disparities in health 
outcomes. Therefore, a logical next step would be to test accelerated 
aging as a marker in a bi-racial cohort with enough power to stratify by 
race. 
4.3. Limitations and strengths 
Our results should be understood in light of a few limitations. First, it 
is never ideal to “adjust out” race, however due to the low prevalence of 
outcomes in our sample we were underpowered to stratify or include 
race interactions. Next, our sample was overall relatively healthy thus 
limiting the generalizability to unhealthy populations. Further, most of 
our individual outcomes had a low prevalence in our study sample 
therefore limiting our power to detect associations. We adjusted for 
smoking and alcohol use rather than modeling them as mediators. 
Although substance use is likely on the pathway from stress to acceler-
ated aging, we are unable to determine if smoking and alcohol use are a 
cause or consequence of the stressors that disadvantage minorities and 
thus, we didn’t expressly model these relationships. Finally, we did not 
include measures of diet and exercise which are known to affect certain 
CVD outcomes and could affect our results. The strengths of our study 
include longitudinal data allowing for temporal relationships between 
variables and that we used a validated method of biological age 
computation including calculations of biological age parameters in a 
reference dataset. 
4.4. Conclusions and future directions 
We have demonstrated that a definition of accelerated aging that is 
based on easily measurable biomarkers partially mediates associations 
between social factors and cardiovascular outcomes, even after adjust-
ment for demographics, smoking, and alcohol consumption. Conceptu-
ally, these findings contribute to our quest to understand how social 
conditions “get under the skin” (Taylor et al., 1997) to affect health 
outcomes. A measure of accelerated aging that shows promise as a 
mechanism for cardiovascular health disparities could serve as a modi-
fiable target in health equity interventions. 
Table 5 
Binary Mediation Coefficients for Accelerated aging at Y20 (2005–2006) Mediating the Relationship between Social Factors at Y15 (2000–2001) and All-cause Mortality 
(2007–2018): CARDIA, 2000–2018.   
Depression Score (Points, Continuous) 
(95% CI) 
Social Participation (Number of groups, 
Continuous) (95% CI) 
Socioeconomic Status Score (Points, 
Continuous) (95% CI) 
Binary Mediation Resultsa Unadjusted Adjustedb Unadjusted Adjusted Unadjusted Adjusted 










Path b 0.23 (0.10, 
0.37) 
0.27 (0.12, 0.42) 0.24 (0.11, 0.37) 0.27 (0.11, 0.42) 0.19 (0.05, 0.33) 0.24 (0.09, 0.40) 












Total Effect of X on Y 0.23 (0.12, 
0.32) 






Percent total effect mediated (% indirect of total 
effect) 
12.45% 4.39% 5.10%% 4.31% 13.42% 9.07% 
The coefficient for Path a corresponds to the association between the independent variable and the mediator; the coefficient for path b corresponds to the association 
between the mediator and the outcome; a*b corresponds to the effect of the mediation. 95% CI of a*b is bias-corrected and tests whether different than zero; The total 
effect of X on Y reports the indirect and direct effect of the independent variable on the outcome; percent total effect mediated is the percentage of the outcome that can 
be attributed to the mediator. 
b Adjusted for sex, chronological age, race, site, smoking status, and mL alcohol per week. 
a Path a = pathway from independent variable (depression score or racial discrimination) to mediator (accelerated aging); Path b = pathway from mediator 
(accelerated aging) to outcome (stroke). 
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